Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 8, 2003, Pages 463-469

  Miller, M ^a   Cespedes, C ^b   Vavagiakis, P ^c   Klein, R S ^d   Lowy, F D ^b  

^a Columbia University ^*  (United States)

^b Apt 2R ^*  (United States)

^c Panna Technologies Inc   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFALOTIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NOSE SMEAR; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SUBSTANCE ABUSE;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV SERONEGATIVITY; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0042911781     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0969-4     Document Type: Article

References (26)

1. Kluytmans J, Belkum A van, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505-520
2. Eiff C von, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344:11-16
3. Jacobson MA, Gellermann H, Chambers H (1988) Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 85:172-176
4. Levine DP, Brown PV (2000) Infections in injection drug users. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, PA, pp 3112-3126
5. Petrosillo N, Viale P, Nicastri E, Arici C, Bombana E, Casella A, et al. (2002) Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis 34:677-685
6. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520-532
7. Holbrook KA, Klein RS, Hartel D, et al. (1997) Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovir 16:301-306
8. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD (1992) Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 11:985-989
9. Ganesh R, Castle D, McGibbon D, Phillips I, Bradbeer C (1989) Staphylococcal carnage and HIV infection. Lancet ii:558
10. Senthilkumar A, Kumar S, Sheagren JN (2001) Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 33:1412-1416
11. Spijkerman IJ, Ameijden EJ van, Mientjes GH, Coutinho RA, Hoek A van den (1996) Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol 49:1149-1154
12. Vlahov D, Sullivan M, Astemborski J, Nelson KE (1992) Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep 107:595-598
13. Charlebois ED, Bangsberg DR, Moss NJ, et al. (2002) Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 34:425-433
14. Lowy FD, Miller M (2002) New methods to investigate infectious disease transmission and pathogenesis: Staphylococcus aureus disease in drug users. Lancet Infect Dis 2:605-612
15. Styrt BA, Chaisson RE, Moore RD (1997) Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients. AIDS 11:1243-1248
16. Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL (1999) Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis 180:1809-1818
17. Schoenbaum EE, Hartel D, Selwyn PA, et al. (1989) Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 321:874-879
18. National Committee for Clinical Laboratory Standards (1997) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. NCCLS, Wayne, PA
19. Oliveira DC, Lencastre H de (2002) Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:2155-2161
20. Belkum A van, Leeuwen W van, Kaufmann ME, et al. (1998) Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. J Clin Microbiol 36:1653-1659
21. Cespedes C, Miller M, Quagliarello B, Vavagiakis P, Klein RS, Lowy FD (2002) Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol 40:2594-2597
22. Quagliarello B, Cespedes C, Miller M, et al. (2002) Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis 35:671-677
23. Roberts RB, Lencastre A de, Eisner W, et al. (1998) Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. J Infect Dis 178:164-171
24. Nguyen MH, Kauffman CA, Goodman RP, et al. (1999) Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 130:221-225
25. Naimi TS, LeDell KH, Boxrud DJ, et al. (2001) Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 33:990-996
26. Centers for Disease Control and Prevention (2003) Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infection - Los Angeles County, California, 2002-2003. Morb Mortal Wkly Rep 52:88-89